Xuyao Zhang

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Cell death & disease

Nucleic acids research

OncoTargets and therapy

Nature cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yichen Wang, Yanyang Nan, Chunguang Ma, Xiaolin Lu, Qian Wang, Xiting Huang, Wenjing Xue, Jiajun Fan, Dianwen Ju, Dingwei Ye, Xuyao Zhang
A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE. Cell death & disease 15 (4) (2024)
Yanyang Nan, Yu Bai, Xiaozhi Hu, Kaicheng Zhou, Tao Wu, An Zhu, Mengyang Li, Zihan Dou, Zhonglian Cao, Xumeng Zhang, Shuwen Xu, Yuanzhen Zhang, Jun Lin, Xian Zeng, Jiajun Fan, Xuyao Zhang, Xuebin Wang, Dianwen Ju
Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy. Journal for immunotherapy of cancer 12 (9) (2024)
Wenjing Xue, Caili Xu, Kaiqi Zhang, Lu Cui, Xiting Huang, Yanyang Nan, Dianwen Ju, Xusheng Chang, Xuyao Zhang
Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer. Cell death discovery 10 (1) (2024)
Yichen Wang, Yanyang Nan, Chunguang Ma, Xiaolin Lu, Qian Wang, Xiting Huang, Wenjing Xue, Jiajun Fan, Dianwen Ju, Dingwei Ye, Xuyao Zhang
A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE. Cell death & disease 15 (4) (2024)
Xiao Wei, Yun Zhao, Wenyue Yan, Qigang Dai, Hui Wu, Yang Miao, Lei Huang, Qing Liu, Xuyao Zhang, Hongxia Wang, Yanan Liu, Linlin Zhang
The Efficacy and Safety of Apatinib and Anlotinib in Advanced Non-Small Cell Lung Cancer. OncoTargets and therapy 17 (2024)
Yichen Wang, Yanyang Nan, Chunguang Ma, Xiaolin Lu, Qian Wang, Xiting Huang, Wenjing Xue, Jiajun Fan, Dianwen Ju, Dingwei Ye, Xuyao Zhang
A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE. Cell death & disease 15 (4) (2024)
Xiao Wei, Yun Zhao, Wenyue Yan, Qigang Dai, Hui Wu, Yang Miao, Lei Huang, Qing Liu, Xuyao Zhang, Hongxia Wang, Yanan Liu, Linlin Zhang
The Efficacy and Safety of Apatinib and Anlotinib in Advanced Non-Small Cell Lung Cancer. OncoTargets and therapy 17 (2024)
Wenjing Xue, Caili Xu, Kaiqi Zhang, Lu Cui, Xiting Huang, Yanyang Nan, Dianwen Ju, Xusheng Chang, Xuyao Zhang
Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer. Cell death discovery 10 (1) (2024)
Zijie Feng, Xin He, Xuyao Zhang, Yuan Wu, Bowen Xing, Alison Knowles, Qiaonan Shan, Samuel Miller, Taylor Hojnacki, Jian Ma, Bryson W Katona, Terence P F Gade, Don L Siegel, Jörg Schrader, David C Metz, Carl H June, Xianxin Hua
Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Nature cancer (2024)
Yanyang Nan, Yu Bai, Xiaozhi Hu, Kaicheng Zhou, Tao Wu, An Zhu, Mengyang Li, Zihan Dou, Zhonglian Cao, Xumeng Zhang, Shuwen Xu, Yuanzhen Zhang, Jun Lin, Xian Zeng, Jiajun Fan, Xuyao Zhang, Xuebin Wang, Dianwen Ju
Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy. Journal for immunotherapy of cancer 12 (9) (2024)
Yuxia Zhang, Wenjing Xue, Caili Xu, Yanyang Nan, Shuang Mei, Dianwen Ju, Shaofei Wang, Xuyao Zhang
Innate Immunity in Cancer Biology and Therapy. International journal of molecular sciences 24 (14) (2023)
Hui Zhao, Yuan Yang, Shuaiqi Wang, Xue Yang, Kaicheng Zhou, Caili Xu, Xuyao Zhang, Jiajun Fan, Dongyue Hou, Xingxiu Li, Hanbo Lin, Ying Tan, Shanshan Wang, Xin-Yi Chu, Dongzhi Zhuoma, Fengying Zhang, Dianwen Ju, Xian Zeng, Yu Zong Chen
NPASS database update 2023: quantitative natural product activity and species source database for biomedical research. Nucleic acids research 51 (D1) (2023)
Hui Zhao, Yuan Yang, Shuaiqi Wang, Xue Yang, Kaicheng Zhou, Caili Xu, Xuyao Zhang, Jiajun Fan, Dongyue Hou, Xingxiu Li, Hanbo Lin, Ying Tan, Shanshan Wang, Xin-Yi Chu, Dongzhi Zhuoma, Fengying Zhang, Dianwen Ju, Xian Zeng, Yu Zong Chen
NPASS database update 2023: quantitative natural product activity and species source database for biomedical research. Nucleic acids research 51 (D1) (2023)
Dongyue Hou, Hanbo Lin, Yuhan Feng, Kaicheng Zhou, Xingxiu Li, Yuan Yang, Shuaiqi Wang, Xue Yang, Jiayu Wang, Hui Zhao, Xuyao Zhang, Jiajun Fan, SongLin Lu, Dan Wang, Lyuhan Zhu, Dianwen Ju, Yu Zong Chen, Xian Zeng
CMAUP database update 2024: extended functional and association information of useful plants for biomedical research. Nucleic acids research (2023)
Hui Zhao, Yuan Yang, Shuaiqi Wang, Xue Yang, Kaicheng Zhou, Caili Xu, Xuyao Zhang, Jiajun Fan, Dongyue Hou, Xingxiu Li, Hanbo Lin, Ying Tan, Shanshan Wang, Xin-Yi Chu, Dongzhi Zhuoma, Fengying Zhang, Dianwen Ju, Xian Zeng, Yu Zong Chen
NPASS database update 2023: quantitative natural product activity and species source database for biomedical research. Nucleic acids research 51 (D1) (2023)
Zijie Feng, Xin He, Xuyao Zhang, Yuan Wu, Bowen Xing, Alison Knowles, Qiaonan Shan, Samuel Miller, Taylor Hojnacki, Jian Ma, Bryson W Katona, Terence P F Gade, Jörg Schrader, David C Metz, Carl H June, Xianxin Hua
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Nature cancer 3 (5) (2022)
Caili Xu, Dianwen Ju, Xuyao Zhang
Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer. Antibody therapeutics 5 (1) (2022)
Xin He, Zijie Feng, Jian Ma, Xuyao Zhang, Sunbin Ling, Yan Cao, Bowen Xing, Yuan Wu, Lei Wang, Bryson W Katona, Carl H June, Xianxin Hua
CAR T cells targeting CD13 controllably induce eradication of acute myeloid leukemia with a single domain antibody switch. Leukemia 35 (11) (2021)
Jiajun Fan, Xuyao Zhang, Shaofei Wang, Wei Chen, Yubin Li, Xian Zeng, Yichen Wang, Jingyun Luan, Li Li, Ziyu Wang, Xilin Sun, Baozhong Shen, Dianwen Ju
Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production. Cell death & disease 10 (9) (2019)

Xuyao Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xuyao Zhang